Navigation Links
Omnicell To Present At Lazard Capital Markets 9th Annual Healthcare Conference
Date:11/7/2012

MOUNTAIN VIEW, Calif., Nov. 7, 2012 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL) a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced they will present at Lazard Capital Markets 9th Annual Healthcare Conference at the Pierre Hotel, New York, NY. 

(Logo: http://photos.prnewswire.com/prnh/20120731/SF48971LOGO-a)

Omnicell Speakers: Randall A. Lipps, founder, chairman, president & CEO and Rob Seim, executive vice president & CFO

Date: Wednesday, November 14, 2012   
Time: 10:30 a.m. ET   
Location: The Pierre Hotel, New York, NY   
Availability: The audio-webcast of the live presentation may be accessed by visiting:    
http://ir.omnicell.com/events.cfm

Following the conference, a replay of the audio-webcast will be archived for 30 days on the Omnicell website.

About Omnicell
Omnicell, Inc. (NASDAQ: OMCL) is a leading provider of automation and business information solutions enabling hospitals and other healthcare organizations to streamline the medication administration process and manage costly medical supplies for increased operational efficiency and enhanced patient safety. Through seamless integration with a customer's existing IT infrastructure, Omnicell solutions empower healthcare facilities to achieve comprehensive automation of medication and supply management from the arrival at the loading dock to the patient's bedside. Omnicell also provides healthcare facilities with business analytics software designed to improve medication diversion detection and regulatory compliance.

Since 1992, more than 2,600 hospital customers worldwide have utilized Omnicell's medication automation, supply chain, and analytics solutions to enable them to increase patient safety, improve efficiency and address changing healthcare regulations while providing effective control of costs, charge capture for payer reimbursement and inventory management of medications and supplies.

MTS Medication Technologies, a wholly-owned Omnicell subsidiary, is a leader in medication adherence packaging systems designed to improve medication dispensing and administration. MTS enables approximately 6,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards while optimizing productivity and controlling costs. The MTS product line includes more than 20 packaging machines and 50 types of consumable products.

For more information about Omnicell, please visit www.omnicell.com. Visit www.mts-mt.com for more information about MTS. 

OMCL-E


'/>"/>
SOURCE Omnicell, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Omnicell Announces Record Revenue and Profit in Third Quarter 2012
2. Omnicell To Present At Think Equitys 9th Annual Growth Conference: G9
3. Omnicell Announces Second Quarter 2012 Results
4. University of South Alabama Health System Selects Omnicell G4 Solutions
5. Omnicell to Release Second Quarter 2012 Earnings Results on August 1
6. Omnicell Repeats Best in KLAS Award for OmniRx Automated Medication Dispensing System
7. Optimer Pharmaceuticals to Present at November 2012 Investor Conferences
8. Isis Pharmaceuticals To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
9. PAREXEL International To Present At Lazard Capital Healthcare Conference And Jefferies Global Healthcare Conference
10. Halozyme Therapeutics To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
11. Array BioPharma To Present Clinical Data On ARRY-797 At The 2012 American College Of Rheumatology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... 2016  The Parenteral Drug Association, Inc. (PDA), ... manufacturing sterile drug products, today announced the publication ... – With link to Comparison Spreadsheet. The ... U.S. FDA, the EU, the Pharmaceutical Inspection Convention/Scheme ... --> --> PDA,s Global Sterile ...
(Date:2/8/2016)... Feb.8, 2016 Cardiovascular Surgery Devices - ... GlobalData,s Medical Devices sector report, "Cardiovascular Surgery Devices ... overview of Cardiovascular Surgery Devices currently in pipeline ... The report provides comprehensive information on the ... at various stages of development. The report reviews ...
(Date:2/8/2016)... FAIRFIELD, N.J. , Feb. 8, 2016  Otsuka ... today announced that they have entered into a licensing ... OPA-15406 in the U.S. and Puerto Rico ... is a topical, non-steroidal phosphodiesterase IV (PDE-4) inhibitor, a ... --> --> In a Phase II ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... February 08, 2016 , ... Stephanie Hebert Insurance ... beginning of a new charity campaign. As part of their ongoing community involvement ... In the belief that children deserve a voice, and in the spirit of ...
(Date:2/8/2016)... ... February 08, 2016 , ... Tingley ... into Canada to provide its range of unique and advantaged protective solutions ... City that will provide bilingual customer service and marketing support. A new distribution ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... announced today that nominations will be accepted February 8, 2016 through May ... , Awards include the Information Security Executive® of the Year, which recognizes ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... lower incidence rate of type 2 diabetes in the GrassrootsHealth cohort with substantially ... to make a change in public health,” states Carole Baggerly, Director of GrassrootsHealth, ...
(Date:2/8/2016)... ... February 08, 2016 , ... The schedule is now online ... AutismOne 2016 Conference, which is being held May 25-29 at the Loews Chicago O’Hare ... helpful interventions and causes of chronic illness in children. , Very recent articles have ...
Breaking Medicine News(10 mins):